A Agilent Technologies, Inc.

A Agilent Technologies, Inc.

Healthcare · Diagnostics & Research

Market read

Scan convergence 1 scan as of 2026-10-16 1 bull converging

POC $138.59 · VWAP $136.61 · +26.6% vs 12m avg buyer

uptrend vol: normalgaps: stablechurn: quiet as of

Insiders quiet 0 buy / 0 sell · Form 4, 90d

Coverage

2 watchlists

Watchlists @biotech-capital-cycle@biotech-scan

A Price Structure

Loading chart…

Loading timeframes…

Peers

Every watchlist A belongs to, members best 30-day change first — A highlighted in place. Each pill: 30d change, 1d/7d, and a close spark over the last 30 calendar days (~21 sessions); hover for price, RSI, and the full chart.

@biotech-capital-cycle
View watchlist →
NAUT+111.9% -4.6%1d -8.4%7d QSI+53.4% -14.5%1d -26.8%7d DNA+45.5% -12.7%1d -21.0%7d PACB+29.1% -11.7%1d -25.8%7d MTD+17.7% -1.0%1d +4.7%7d CERT+15.3% -3.0%1d +2.6%7d ILMN+14.7% -2.0%1d -5.6%7d FTRE+12.6% -1.1%1d +7.9%7d A+12.5% -1.5%1d +1.4%7d DHR+9.9% -1.1%1d +4.2%7d CRL+9.8% -2.0%1d -0.5%7d RXRX+8.8% -16.6%1d -20.4%7d SEER+6.8% -0.5%1d -7.3%7d TMO+6.4% -0.9%1d +4.9%7d AVTR+5.2% +2.0%1d +4.8%7d RVTY+4.7% -1.3%1d -1.0%7d WAT+4.4% -1.6%1d +0.7%7d ABSI+2.6% -7.1%1d -18.8%7d RGEN+1.4% -4.8%1d +0.9%7d ABCL+1.1% -6.9%1d -6.0%7d MEDP+0.3% -1.6%1d +1.1%7d IQV-0.7% -1.5%1d +2.7%7d QTRX-1.4% -6.5%1d -12.5%7d ICLR-2.2% -2.8%1d +3.7%7d TXG-3.9% -3.5%1d -13.4%7d AGIO-5.0% -3.1%1d -1.5%7d SDGR-5.6% -11.3%1d -17.2%7d XBI-6.4% -3.6%1d -6.2%7d TWST-7.2% -8.1%1d -16.9%7d CDXS-7.5% -8.8%1d -12.1%7d TEM-7.5% -9.0%1d -8.8%7d BRKR-9.7% -3.1%1d -6.9%7d LAB-11.3% -4.5%1d -8.8%7d ALMR-14.0% -7.8%1d 0.0%7d VKTX-14.7% -8.0%1d -11.7%7d GENB-22.9% -7.4%1d -15.7%7d
@biotech-scan
View watchlist →
GRAL+56.9% -13.0%1d -16.2%7d MRNA+49.7% -7.8%1d -3.1%7d DNA+45.5% -12.7%1d -21.0%7d AMGN+14.9% -0.3%1d +4.3%7d ILMN+14.7% -2.0%1d -5.6%7d RARE+12.9% -4.2%1d -6.1%7d A+12.5% -1.5%1d +1.4%7d ISRGE+11.6% -0.3%1d +0.7%7d LLY+10.5% +0.4%1d +6.6%7d DHR+9.9% -1.1%1d +4.2%7d RXRX+8.8% -16.6%1d -20.4%7d ABBV+8.7% +0.7%1d +3.2%7d LEGN+8.7% -6.7%1d -0.8%7d BIIB+7.7% -1.1%1d +3.1%7d TMO+6.4% -0.9%1d +4.9%7d GILD+5.8% -0.8%1d +3.3%7d MDT+2.3% -0.7%1d +7.1%7d REGN+2.1% -0.7%1d +5.9%7d BEAM+1.6% -5.1%1d -8.7%7d IBB-0.2% -2.6%1d -2.2%7d NTLA-0.6% +0.7%1d -12.6%7d IQV-0.7% -1.5%1d +2.7%7d DXCM-1.5% -1.9%1d +2.3%7d IBBQ-1.9% -2.7%1d -2.6%7d VRTX-2.6% -1.8%1d -2.0%7d ALNY-3.1% -0.9%1d -0.4%7d IONS-4.2% -2.7%1d -5.2%7d CRSP-5.7% -4.4%1d -7.8%7d XBI-6.4% -3.6%1d -6.2%7d NVO-6.9% -1.0%1d +0.5%7d BNTX-8.5% -2.8%1d -9.5%7d COGT-9.3% 0.0%1d -4.8%7d INCY-9.4% -0.2%1d +0.3%7d PTGX-9.9% -5.7%1d -10.4%7d KYMR-9.9% -3.1%1d -6.8%7d EDIT-13.3% -3.7%1d -19.0%7d SRPT-13.5% -3.9%1d -4.2%7d BMRN-15.5% -2.4%1d -0.2%7d IMVT-26.5% -2.8%1d -12.3%7d NKTR-46.9% -5.1%1d -13.1%7d

Decision history

1 scored call · newest first · projection

How to read this: Positive 30-day excess supports an enter call. For pass, avoid, sell, or exit calls, a positive number means the name kept rising after the call.

May 30 sell n/a Profit target -0.3% complete

Next earnings A reports in 39 days Nov 25

Last report Aug 26

Reported EPS $1.62 versus analyst consensus of $1.49 (+9.0%).

full note →

Against street estimates

How A's reported EPS compared with analyst consensus. Street estimates are single-source vendor consensus (yfinance). Actuals are vendor consensus-basis EPS (often non-GAAP); edgarEps is GAAP diluted from filings — disputed flags large disagreement only. EPS only.

8 most recent of 10 quarters · newest report Aug 26 · projection Oct 16

Result
Aug 26 1.491.62+9.0%Beat
May 27 1.411.49+5.8%Beat
Feb 25 1.371.36-0.6%In line
Nov 24 '25 1.581.59+0.4%In line
Aug 27 '25 1.371.37+0.2%In line
May 28 '25 1.261.31 GAAP ≠ +3.6%Beat
Feb 26 '25 1.271.31+3.0%Beat
Nov 25 '24 1.411.46+3.9%Beat

A research tape

40 dated scans, research, and events, newest first — the full record. Desk commentary and scheduled prints sit in their own panes.

scan Biotech Scan — October 16, 2026 scan Monster Scan — 2026-10-15 scan Biotech Scan — October 9, 2026 scan Biotech Scan — October 2, 2026 scan Monster Scan — 2026-09-30
Types
Oct 16 Scan Biotech Scan
IMVTBMRNNKTRINCYNVOCOGTIONSREGN +4 more
Oct 15 Scan Monster Scan
005930.KS009150.KS1888.HK2308.TW2383.TW2449.TW2802.T3037.TW +4 more
Oct 9 Scan Biotech Scan
IMVTBMRNNKTRINCYNVOCOGTIONSREGN +4 more
Oct 2 Scan Biotech Scan
NKTRBMRNNVOIMVTIONSINCYALNYREGN +4 more
Sep 30 Scan Monster Scan
AAAMIAAOIAAPLABCLABNBABSIACMR +4 more
Sep 29 Scan Monster Scan
AAAMIAAOIABCLABSIACMRADIADM +4 more
Sep 28 Scan Monster Scan
AAAMIAAOIAAPLABCLABSIACMRADI +4 more
Sep 28 Scan Monster Discover
AAAMIABCLADPTAEHRALABALVOAMCE +4 more
Sep 25 Scan Biotech Scan
ABBVGILDAMGNREGNBIIBLLYVRTXNVO +4 more
Sep 25 Scan Monster Scan
AAAMIAAOIAAPLABCLABSIACMRADI +4 more
Sep 25 Scan Monster Discover
AAAMIABCLADPTAEHRALABALVOAMCE +4 more
Sep 24 Scan Monster Scan
AAAMIAAOIAAPLABCLABSIACMRADI +4 more
Sep 24 Scan Monster Discover
AAAMIABCLADPTAEHRALABALVOAMCE +4 more
Sep 23 Scan Biotech Scan
ABBVGILDAMGNREGNBIIBLLYVRTXNVO +4 more
Sep 23 Scan Monster Scan
AAAMIAAOIAAPLABCLABSIACMRADI +4 more
Sep 22 Scan Monster Scan
AAAMIAAOIAAPLABCLABSIACMRADI +4 more
Sep 18 Scan Biotech Scan
ABBVGILDAMGNREGNBIIBLLYVRTXNVO +4 more
Sep 11 Scan Biotech Scan
ABBVGILDAMGNREGNBIIBLLYVRTXNVO +4 more
Sep 4 Scan Biotech Scan
ABBVGILDAMGNREGNBIIBLLYVRTXNVO +4 more
Aug 28 Market Brief Beats Nobody Paid For
AEMANFAVDVAVUVBFLYCAMTKAROELPG +4 more
Aug 28 Scan Biotech Scan
ABBVGILDAMGNREGNBIIBLLYVRTXNVO +4 more
Aug 27 Market Brief A Risk-On Turn, Confirmed Three Ways
ABCLANETAPHARKKBESIYBHPNVDACRM +4 more
Aug 27 The Prints The Prints
NVDACRMANFADYPLABLI
Aug 26 Catalyst A earnings
A
Aug 22 Scan Biotech Scan
ABBVGILDAMGNREGNBIIBLLYVRTXNVO +4 more
Aug 18 Market Brief The AI Trade Cracked. The Market Didn't.
AALMAMPATRCAVAHBNHDBIDU +4 more
Aug 14 Scan Biotech Scan
ABBVGILDAMGNREGNBIIBLLYVRTXNVO +4 more
Aug 8 Scan Biotech Scan
ABBVGILDAMGNREGNBIIBLLYVRTXNVO +4 more
Aug 8 Market Brief One Jobs Print, and Everything Repriced
AADMALSNAMVMFAUDXPEFTDRGHRS +4 more
Jul 31 Scan Biotech Scan
ABBVGILDAMGNREGNBIIBLLYVRTXNVO +4 more
Jul 28 Scan Biotech Scan
ABBVGILDAMGNREGNBIIBLLYVRTXNVO +4 more
Jul 25 Scan Biotech Scan
ABBVGILDAMGNREGNBIIBLLYVRTXNVO +4 more
Jul 17 Scan Biotech Scan
ABBVGILDAMGNREGNBIIBLLYVRTXNVO +4 more
Jul 11 Scan Biotech Scan
ABBVXBIIBBIBBQLABUMRNABIIBLLY +4 more
Jul 7 Scan Biotech Scan
ABBVXBIIBBIBBQLABUMRNABIIBLLY +4 more
Jun 26 Scan Biotech Scan
ABBVXBIIBBIBBQLABUMRNABIIBLLY +4 more
Jun 16 Scan Biotech Scan
ABBVGILDAMGNREGNBIIBLLYVRTXNVO +4 more
May 29 Scan Biotech Scan
AABBVALNYAMGNBEAMBIIBBMRNBNTX +4 more
May 27 Catalyst A earnings
A
Mar 13 Desk Move BUY A — bench-signals (2026-03-13, 8.93 shares @ $111.94)
A